198 related articles for article (PubMed ID: 29773998)
1. Larger Gray Matter Volume in the Basal Ganglia of Heavy Cannabis Users Detected by Voxel-Based Morphometry and Subcortical Volumetric Analysis.
Moreno-Alcázar A; Gonzalvo B; Canales-Rodríguez EJ; Blanco L; Bachiller D; Romaguera A; Monté-Rubio GC; Roncero C; McKenna PJ; Pomarol-Clotet E
Front Psychiatry; 2018; 9():175. PubMed ID: 29773998
[No Abstract] [Full Text] [Related]
2. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
[TBL] [Abstract][Full Text] [Related]
3. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls.
Cousijn J; Wiers RW; Ridderinkhof KR; van den Brink W; Veltman DJ; Goudriaan AE
Neuroimage; 2012 Feb; 59(4):3845-51. PubMed ID: 21982932
[TBL] [Abstract][Full Text] [Related]
4. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
[TBL] [Abstract][Full Text] [Related]
5. Regional brain abnormalities associated with long-term heavy cannabis use.
Yücel M; Solowij N; Respondek C; Whittle S; Fornito A; Pantelis C; Lubman DI
Arch Gen Psychiatry; 2008 Jun; 65(6):694-701. PubMed ID: 18519827
[TBL] [Abstract][Full Text] [Related]
6. Age-related changes in cortical and subcortical structures of healthy adult brains: A surface-based morphometry study.
Zheng F; Liu Y; Yuan Z; Gao X; He Y; Liu X; Cui D; Qi R; Chen T; Qiu J
J Magn Reson Imaging; 2019 Jan; 49(1):152-163. PubMed ID: 29676856
[TBL] [Abstract][Full Text] [Related]
7. Do manual and voxel-based morphometry measure the same? A proof of concept study.
Focke NK; Trost S; Paulus W; Falkai P; Gruber O
Front Psychiatry; 2014; 5():39. PubMed ID: 24782790
[TBL] [Abstract][Full Text] [Related]
8. Previous glucocorticoid treatment in childhood and adolescence is associated with long-term differences in subcortical grey matter volume and microstructure.
Holm SK; Madsen KS; Vestergaard M; Born AP; Paulson OB; Siebner HR; Uldall P; Baaré WFC
Neuroimage Clin; 2019; 23():101825. PubMed ID: 31004915
[TBL] [Abstract][Full Text] [Related]
9. Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume.
Wetherill RR; Jagannathan K; Hager N; Childress AR; Rao H; Franklin TR
Int J Neuropsychopharmacol; 2015 Jun; 18(10):pyv061. PubMed ID: 26045474
[TBL] [Abstract][Full Text] [Related]
10. Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users.
Gilman JM; Kuster JK; Lee S; Lee MJ; Kim BW; Makris N; van der Kouwe A; Blood AJ; Breiter HC
J Neurosci; 2014 Apr; 34(16):5529-38. PubMed ID: 24741043
[TBL] [Abstract][Full Text] [Related]
11. Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms.
Huijbregts SC; Loitfelder M; Rombouts SA; Swaab H; Verbist BM; Arkink EB; Van Buchem MA; Veer IM
J Neurodev Disord; 2015; 7():32. PubMed ID: 26473019
[TBL] [Abstract][Full Text] [Related]
12. Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol.
Demirakca T; Sartorius A; Ende G; Meyer N; Welzel H; Skopp G; Mann K; Hermann D
Drug Alcohol Depend; 2011 Apr; 114(2-3):242-5. PubMed ID: 21050680
[TBL] [Abstract][Full Text] [Related]
13. Individuals with cannabis use are associated with widespread morphological alterations in the subregions of the amygdala, hippocampus, and pallidum.
Cong Z; Fu Y; Chen N; Zhang L; Yao C; Wang Y; Yao Z; Hu B
Drug Alcohol Depend; 2022 Oct; 239():109595. PubMed ID: 35961268
[TBL] [Abstract][Full Text] [Related]
14. Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users.
Schacht JP; Hutchison KE; Filbey FM
Neuropsychopharmacology; 2012 Oct; 37(11):2368-76. PubMed ID: 22669173
[TBL] [Abstract][Full Text] [Related]
15. Effect of alcohol, tobacco, and cannabis co-use on gray matter volume in heavy drinkers.
Grodin EN; Burnette E; Towns B; Venegas A; Ray LA
Psychol Addict Behav; 2021 Sep; 35(6):760-768. PubMed ID: 34435833
[TBL] [Abstract][Full Text] [Related]
16. Testing associations between cannabis use and subcortical volumes in two large population-based samples.
Gillespie NA; Neale MC; Bates TC; Eyler LT; Fennema-Notestine C; Vassileva J; Lyons MJ; Prom-Wormley EC; McMahon KL; Thompson PM; de Zubicaray G; Hickie IB; McGrath JJ; Strike LT; Rentería ME; Panizzon MS; Martin NG; Franz CE; Kremen WS; Wright MJ
Addiction; 2018 Apr; ():. PubMed ID: 29691937
[TBL] [Abstract][Full Text] [Related]
17. Brain Volume Correlates with Duration of Abstinence from Substance Abuse in a Region-Specific and Substance-Specific Manner.
Korponay C; Kosson DS; Decety J; Kiehl KA; Koenigs M
Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Oct; 2(7):626-635. PubMed ID: 29308437
[TBL] [Abstract][Full Text] [Related]
18. Subcortical Volumes Differ in Parkinson's Disease Motor Subtypes: New Insights into the Pathophysiology of Disparate Symptoms.
Rosenberg-Katz K; Herman T; Jacob Y; Kliper E; Giladi N; Hausdorff JM
Front Hum Neurosci; 2016; 10():356. PubMed ID: 27462214
[TBL] [Abstract][Full Text] [Related]
19. Differences in brain structure in patients with distinct sites of chronic pain: A voxel-based morphometric analysis.
Mao C; Wei L; Zhang Q; Liao X; Yang X; Zhang M
Neural Regen Res; 2013 Nov; 8(32):2981-90. PubMed ID: 25206618
[TBL] [Abstract][Full Text] [Related]
20. Volumetric gray matter measures of amygdala and accumbens in childhood overweight/obesity.
Perlaki G; Molnar D; Smeets PAM; Ahrens W; Wolters M; Eiben G; Lissner L; Erhard P; Meer FV; Herrmann M; Janszky J; Orsi G;
PLoS One; 2018; 13(10):e0205331. PubMed ID: 30335775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
